The effect of KAMIKIHITO on the cancer-related fatigue

The effect of KAMIKIHITO on the cancer-related fatigue - KAMIKIHITO study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021156

Enrollment

Registered

2016-02-23

Start date

2014-07-29

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic cancer-related fatigue

Interventions

administration of Kamikihito

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients under cancer drug therapy

Exclusion criteria

Exclusion criteria: heart disease lung desease

Design outcomes

Primary

Measure	Time frame
effectiveness of Kamikihito in cancer-related fatigue	—

Secondary

Measure	Time frame
scientific effectivness ofKamikihito in cancer-related fatigue	—

Countries

Japan

Contacts

Public ContactSatoshi Tamada

Osaka City University Urology

s-tamada@med.osaka-cu.ac.jp06-6645-3857

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026